Valuation (66%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 38.98 | N/A |
| PEG Ratio (TTM) | -1.56 | N/A |
| P/S Ratio (TTM) | 1.72 | N/A |
| P/B Ratio (TTM) | 1.39 | N/A |
| P/FCF Ratio (TTM) | 10.83 | N/A |
| Price to 5YR AVG Earnings Ratio | 15.58 | N/A |
| Price to 5YR AVG FCF Ratio | 7.54 | N/A |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.82% | N/A |
| ROE (TTM) | 3.36% | N/A |
| Net Profit Margin (TTM) | 4.53% | N/A |
| ROIC 5YR AVG | 9.34% | N/A |
Growth (65%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 59.79% | 58.75% | 11.89% |
| Revenue | 1.81% | 5.77% | 2.71% |
| Net Income | 59.31% | 57.44% | 11.11% |
| Cash Flow | 21.26% | 8.85% | -2.62% |
Health (65%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.42 | N/A |
| Quick Ratio (TTM) | 1.42 | N/A |
| D/E Ratio (TTM) | 0.49 | N/A |
| Interest Coverage (TTM) | 13.80 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 2.01 | N/A |
| LTL to 5YR AVG FCF | 3.24 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.64% | N/A |